6CM
COYA icon

683 Capital Management’s Coya Therapeutics COYA Stock Holding History

683 Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70,000
Closed -$276K – 176
2026
Q1 		$276K Sell
70,000
-10,128
-13% -$47.4K 0.01% 209
2025
Q4 		$465K Buy
+80,128
New +$487K 0.02% 198

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

683 Capital Management's COYA Position: Q2 2026 in Review

683 Capital Management sold out of Coya Therapeutics (COYA) in Q2 2026, closing a stake of 70,000 shares — an estimated $276K sold.

683 Capital Management first reported a position in COYA in Q4 2025 and held it in 2 quarters. The position peaked at $465K in Q4 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • 683 Capital Management reported no remaining Coya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • 683 Capital Management sold 70,000 Coya Therapeutics shares in Q2 2026, an estimated $276K.
  • 683 Capital Management first reported a position in Coya Therapeutics in Q4 2025 and held it in 2 quarters.
  • 683 Capital Management's Coya Therapeutics position peaked at $465K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.